Mais la polymyxine n'est pas du tout absorbée dans le sang du système gastro-intestinal et n'a d'effet que dans l'intestin et est utile pour le traitement des infections intestinales doxycycline prix Internet en y faisant des achats permettant d’économiser jusqu'à soixante-dix pour cent, tout en étant sûr de la qualité des produits pharmaceutiques.

Safety data sheet

MATERIAL SAFETY DATA SHEET
HOLDIT S57

SECTION 1. IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Product Name
:
HOLDIT S57

Other Names:

Instant Pipe Seal with Teflon

Part Number:

S57-50 (50ml), S57-250 (250ml)

Supplier:

Address:

Emergency Tel:
Telephone:
Emergency Contact
Address:


Other Information:
The information below is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. This Company shall not be held liable for any damage resulting from handling or from contact with the above product.
SECTION 2. HAZARDOUS IDENTIFICATION
Hazard Category
:

Risk Phrases:
R36/38 Irritating to eyes, respiratory system and skin. R43 May cause sensitization by skin contact
Safety Phrases:
S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice S27 Take off immediately all contaminated clothing. S28 After contact with skin, wash immediately with plenty of water S3/14 keep in a cool place. S3/9/14 Keep in a cool, well ventilated place away from direct sunlight S37 Wear suitable gloves S37/39 Wear suitable gloves and eye/face protection S39 Wear eye/face protection S7 Keep container tightly closed S9 Keep container in a well ventilated place MATERIAL SAFETY DATA SHEET
HOLDIT S57

SECTION 3. COMPOSITION/INFORMATION OF INGREDIENTS

OTHER LIMITS
Chemical Name
RECOMMENDED

SECTION 4. FIRST AID MEASURES
Eye Contact:

A primary route of exposure that will cause eye irritation characterized by excessive tearing, redness and blinking. FIRST AID:
Flush eyes with generous amounts of water for 20-30 minutes, lifting both upper and lower eyelids occasionally. Get medical attention. Skin Contact:
A primary route of exposure that may cause moderate skin irritation and allergic skin reaction. May cause rash, redness, swelling and blistering (symptoms may be delayed). FIRST AID:
Thoroughly wash exposed area with soap and water. If irritation develops, seek medical attention. Launder clothing before reuse. Inhalation:
As supplied; not significant hazard. However vapours generated at elevated temperatures, may cause respiratory tract irritation. Symptoms may include coughing, mucous production and shortness of breath. FIRST AID:
If overcome by exposure, victim should be removed to fresh air immediately. Give artificial respiration as needed. Get immediate medical attention. Ingestion:
Ingestion may cause irritation of the gastrointestinal tract and depression of the central nervous system leading to loss of consciousness. FIRST AID:
Do not induce vomiting. Immediately seek medical attention. Chronic Effects:
Material or its emissions may defat skin, cause contact dermatitis and thereby aggravate exisiting skin or systemic diseases. Carcinogenic

SECTION 5. FIRE FIGHTING MEASURES
Flash Point:
200°C
Auto Ignition Temperature: Not determined.
Flammability limits % in Air: LEL: not determined
Extinguishing Media:
Water spray, foam, dry chemical, or carbon dioxide. Special Firefighting:
Wear a NOISH approved self-contained breathing apparatus with full face piece operated in pressure-demand or other positive pressure mode when fighting fires. Cool fire exposed containers. Unusual Fire Hazards &
Conditions to avoid:
RECOMMENDED NFA/HMIS RATING
Health 1
Flammability 1
Reactivity 0
Personal Protection C
Note: ratings may differ according to application, environment, and physical state. MATERIAL SAFETY DATA SHEET
HOLDIT S57

SECTION 6. ACCIDENTIAL RELEASE MEASURES
Steps to be taken if material is spilled or released:

Absorb material on inert filler, vermiculite, floor absorb or other absorbent material. Transfer to ventilated area and dispose of properly.
Waste Disposal Methods:
Dispose of material in accordance with local, state and federal regulations. Safe Handling & Storage:
Avoid prolonged skin contact. Store product in a cool dry place. Other precautions and special hazardous Information: This material contains inhibitors which upon depletion can result
in an excessive thermal reaction.
SECTION 7. HANDLING AND STORAGE
Precautions for safe handling

Conditions for safe storage, including any incompatibilities

Frost sensitive. Do not freeze. Store in a cool dry place.
SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Respiratory Protection:

For normal use respiratory protection is not required. Protective Gloves:
Eye Protection:
Wear NIOSH approved safety goggles with side shields. Ventilation used:
Protective Clothing &
Equipment:

Wear impervious clothing to prevent repeated, prolonged skin contact. Hygienic Work Practices:
Practice good hygiene, and wash hands after using this product.
SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES
Boiling Point:

Vapour Density:
VOC #/gal:
Vapour Pressure:
Density of Coating:
Melting Point:
Specific Gravity:
Evaporation Rate:
Water Reactive:
Solubility in Water:
Appearance:
Odour: Mild Odour

SECTION 10. STABILITY AND REACTIVITY
Stability:

Stable: x
Unstable:
Hazardous Polymerization:
May occur:
will not occur: x
Conditions to avoid:
Avoid elevated temperatures above 37°C, contamination with incompatible materials. Incompatibility:
Hazardous Decomposition Products: None known.


MATERIAL SAFETY DATA SHEET
HOLDIT S57

SECTION 11. TOXICOLOGY INFORMATION
Component

ORAL LD50
DERMAL LD50
INHALATION LC50
>10,000 mg/kg (Rabbit) 6.82 mg/l (Rat)
SECTION 12. ECOLOGICAL INFORMATION

This product can be harmful to aquatic organisms. Do not allow to contaminate waterways or soil.
SECTION 13. DISPOSAL CONSIDERATIONS
Steps to be taken if material is spilled or released.
Dike or contain spill with inert materials and transfer liquid to containers for recovery or disposal. Avoid runoff into storm
sewers or into waterways. Immediately extinguish all sources of ignition, flame, heat, etc. until area is free from explosive
hazard. Absorb material in inter filler or floor absorb and transfer to a ventilated area for proper disposal.
Waste Disposal Methods:
Discharge, treatment, or disposal may be subject to national, state or local laws. Based on our knowledge of the product, its
raw materials and processes employed during its manufacture, we believe it is unlikely that this product is hazardous waste
for federal RCRA purposes. We recommend that you carry out your own tests and evaluations prior to discarding any
materials.
SECTION 14. TRANSPORT INFORMATION
ADR/RID

The product is not classified as dangerous for carriage. The product is not classified as dangerous for carriage. The product is not classified as dangerous for carriage.
SECTION 15. REGULATORY INFORMATION
None Allocated
MATERIAL SAFETY DATA SHEET
HOLDIT S57

SECTION 16. OTHER INFORMATION
Detaching this notification from the Material Safety Data Sheet is prohibited by law and any copying or distribution
of same requires this attachment be included.
This products contains the following toxic chemicals subject to the reporting requirements of section 313 of the
Emergency Planning and Community Right-To-Know Act 1986 and 40 CFR 372:
CHEMICAL NAME
% BY WEIGHT
This product contains the following materials that under California Proposition 65 of the Safe Drinking Water and
Toxic Enforcement Act of 1986 are recognized to cause cancer or reproductive toxicity.

Concentration
Reproductive
Material

CONTACT POINT
Technical Contact

Source: http://www.holdit.com.au/__files/f/4926/HOLDIT%20S57%20MSDS.pdf

aponet.at

Chronologie einer Krankheit von Gerhard Klein * *DI: Gerhard Klein ist seit 1998 bei der Aids Hilfe Wien als Mitarbeiter für ProjektPrävention beschäftigt. 1981 Ein Drogentechniker am Center for Disease Control in den USA bemerkt eine ungewöhnlich hohe Anfrage nach Pentamidine -eine Droge, die in der Behandlung von Pneumocystis Carinii Pneumonia (PCP) verwendet wird. Sp

farmakonomuddannelsen.dk

Pharm World Sci (2006) 28:239–247DOI 10.1007/s11096-006-9023-9Drug-related problems in patients with angina pectoris, type 2diabetes and asthma – interviewing patients at homeLotte Stig Haugbølle Æ Ellen Westh SørensenReceived: 12 January 2006 / Accepted: 12 April 2006 / Published online: 26 October 2006Ó Springer Science+Business Media B.V. 2006‘‘Other problems’’ (such as limi

Copyright © 2010-2014 Medical Science